• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Endocare

Endocare

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Global Blowing Agents Market Analysis & Trends - Industry Forecast to 2025 - Research and Markets

    Global Blowing Agents Market Analysis & Trends - Industry Forecast to 2025 - Research and Markets

  2. Global Neuropathy Pain Treatment Market Projected to be Worth USD 6,985 Million by 2021: Technavio

    Global Neuropathy Pain Treatment Market Projected to be Worth USD 6,985 Million by 2021: Technavio

  3. Syntimmune Announces Breakthrough Results of FcRn Inhibition Published in PNAS

    Syntimmune Announces Breakthrough Results of FcRn Inhibition Published in PNAS

  4. GI Dynamics Announces Scientific Advisory Board Members to Further Scientific Understanding of EndoBarrier

    GI Dynamics Announces Scientific Advisory Board Members to Further Scientific Understanding of EndoBarrier

  5. Energy Based Ablation Devices - Global Strategic Business Report 2017 - Research and Markets

    Energy Based Ablation Devices - Global Strategic Business Report 2017 - Research and Markets

  6. The Market: Exaggerated Woes

    Endo Pharmaceuticals ENDP announced July 11 that it no longer expects to file a new drug application for its ketoprofen pain-relief patch by the first half of 2008 because of lackluster Phase III trial results. The drug candidate failed to show statistically significant results for pain relief in ...

  7. Health Care: 3 Picks in a More Expensive Sector

    Despite the sector looking slightly overvalued overall, we still see stocks that offer attractive valuations across the different industries.

  8. Credit Market Outlook: Tight Spreads Will Keep a Lid on Returns

    As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.

12

©2017 Morningstar Advisor. All right reserved.